2'-O-MOE-5-Methyl-Uridine Phosphoramidite is a chemically modified phosphoramidite building block used as a pharmaceutical intermediate in oligonucleotide synthesis. It incorporates a 2'-O-(2-methoxyethyl) (MOE) modification and a 5-methyluridine base, which enhance the stability and binding properties of synthetic oligonucleotides for research applications.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 163878-63-5
5'-Dimethoxytrityl-3'-deoxythymidine 2'-[(2-cyanoethyl)-(N,N-diisopropyl)]-phosphoramidite
pharmaceutical intermediate
N-Benzoyl-5'-O-(4,4'-dimethoxytrityl)-3'-O-((2-cyanoethoxy)(diisopropylamino)phosphino)-2'-O-(2-methoxyethyl)-5-methylcytidine
pharmaceutical intermediate
(2R,3R,4R,5R)-2-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-((tert-butyldimethylsilyl)oxy)-5-(5-fluoro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite
research compound
5'-O-(4,4'-Dimethoxytrityl)-N6-benzoyl-2'-deoxyadenosine-3'-(2-cyanoethyl-N,N-diisopropyl)phosphoramidite
pharmaceutical intermediate
Mc-Val-Cit-PAB-Cl
pharmaceutical intermediate
2-((2,2-Diphenylvinyl)oxy)-4,6-dimethylpyrimidine
pharmaceutical intermediate
MC-Val-Ala-PAB-PNP
pharmaceutical intermediate
2,3,3-Trimethylindolenine
pharmaceutical intermediate
3-[[(2R,3R,4R,5R)-2-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-(2-methoxyethoxy)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-[di(propan-2-yl)amino]phosphanyl]oxypropanenitrile
YFRRKZDUDXHJNC-KZQAAKLLSA-N
CC1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)COC(C3=CC=CC=C3)(C4=CC=C(C=C4)OC)C5=CC=C(C=C5)OC)OP(N(C(C)C)C(C)C)OCCC#N)OCCOC